Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Aug;70(2):761-762.
doi: 10.1002/hep.30642.

Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?

Andrew M Moon  1 , Paul H Hayashi  1 , A Sidney Barritt 4th  1
Affiliations
Comment

Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?

Andrew M Moon et al. Hepatology. 2019 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None

Comment in

  • Reply.
    Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. Nardelli S, et al. Hepatology. 2019 Aug;70(2):762-763. doi: 10.1002/hep.30639. Hepatology. 2019. PMID: 30945757 No abstract available.

Comment on

References

    1. Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics. Hepatology. 2018. - PubMed
    1. Nehra AK, Alexander JA, Loftus CG, Nehra V. Proton Pump Inhibitors: Review of Emerging Concerns. Mayo Clin Proc. 2018;93(2):240–246. - PubMed
    1. Hvid-Jensen F, Nielsen RB, Pedersen L, et al. Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting. Clin Epidemiol. 2013;5:493–499. - PMC - PubMed